All News

Found 9,342 articles

• Sanofi-Aventis (New Jersey) Announces New U.S. Headquarters Location

  11/7/2005

• Genta Incorporated Announces 3rd Quarter 2005 Financial Results

  11/7/2005

• Shire Pharmaceuticals Group plc: Investing In A Promising Future

  11/3/2005

• Cytogen Corporation Reports Third Quarter 2005 Financial Results

  11/3/2005

• Debiopharm S.A. And EPFL Launch The'Debiopharm Life Sciences Award' For European Oncology Researchers

  11/3/2005

• Sanofi-Aventis Japan To Merge Sanofi-Synthelabo And Aventis Pharma Japan In January

  11/2/2005

• Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Announces Clinical Updates At Analyst Day Meeting

  11/2/2005

• IDM Pharma, Inc. To Present At Rodman And Renshaw Techvest 7th Annual Healthcare Conference

  11/2/2005

• Inyx, Inc. To Present At Rodman & Renshaw Healthcare Conference

  11/2/2005

• Founder Dr. Ken M. Kengatharan Joins Athenagen Inc. To Lead Pre-clinical R&D

  11/1/2005

• Eisai Company, Ltd. Announces Agreement To License Novel Adjuvant From Sanofi Pasteur

  10/31/2005

• Enzon Pharmaceuticals, Inc. Announces Amendment To ONCASPAR Agreement With Members Of The Sanofi-Aventis (SASY.PA) Group

  10/31/2005

• IDM Pharma, Inc. Confirms Plans To Submit A Marketing Authorization Application (Maa) To European Regulators For Approval Of Junovan(Tm) For The Treatment Of Osteosarcoma Following Pre-Maa Meeting With Emea

  10/31/2005

• Coley Pharmaceutical Group To Present At The JPMorgan Small Cap Conference

  10/31/2005

• US FDA Delays Decision For Sanofi-Aventis (France) Inhaled Insulin

  10/28/2005

• U.S. Department Of Health And Human Services Release: HHS Buys Additional Vaccine As Preparations For Potential Influenza Pandemic Continue

  10/28/2005

• Bristol-Myers Squibb Company Reports Financial Results For The Third Quarter And First Nine Months Of 2005, Reflecting Ongoing Investments In Strategy Aimed At Delivering Sustainable Growth

  10/28/2005

• Sanofi-Aventis (France) Release: Study Demonstrates That BenzaClin(R) Topical Gel (Clindamycin 1% - Benzoyl Peroxide 5% Gel) Provided A Numerically Greater Reduction In Acne Lesions Than Tretinoin 0.025% Gel Plus Clindamycin 1% Gel

  10/27/2005

• Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Reports Strong Third Quarter 2005 Financial Results

  10/27/2005

• Keryx Biopharmaceuticals Announces Final Phase II Data Presentation On KRX-101 At The Upcoming Conference

  10/24/2005